Lymphocyte subsets, granulocytecolony-stimulating factor responsiveness and post-stem cell transplantation infections: Mucositis is the underestimated confounder?

Cytotherapy

Volumn 14, Issue 3, 2012, Pages 381-383

  Van Der Velden, W J F M ^a   Donnelly, J P ^a   Blijlevens, N M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Citrulline; Fever; Granulocytecolony stimulating factor; High dose melphalan; Infection; Lymphocyte subset; Mucositis; Stem cell transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTEREMIA; DRUG MEGADOSE; FEVER; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; LYMPHOCYTE HOMING; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; STOMATITIS; T LYMPHOCYTE SUBPOPULATION; CD4+ T LYMPHOCYTE; FEMALE; MALE; METABOLISM; MULTIPLE MYELOMA; NOTE; STEM CELL TRANSPLANTATION;

CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INFECTION; MALE; MELPHALAN; MULTIPLE MYELOMA; STEM CELL TRANSPLANTATION;

EID: 84856894613     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.650162     Document Type: Letter

References (10)

1. + lymphocytes on day 5 after high-dose melphalan for multiple myeloma predict a low risk of infections during severe neutropenia and are associated with the number of reinfused T lymphocytes of the autologous stem cell graft. Cytotherapy. 2011;13:987-92.
2. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19:2201-5. (Pubitemid 32372323)
3. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98:1531-9. (Pubitemid 37151510)
4. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36:1103-10. (Pubitemid 36553108)
5. van der Velden WJ, Herbers AH, Feuth T, Schaap NP, Donnelly JP, Blijlevens NM. Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS ONE. 2010;5:e15156.
6. van der Velden WJ, Blijlevens NM, Feuth T, Donnelly JP. Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant. 2009;43:55-60.
7. Chakraverty R, Cote D, Buchli J, Cotter P, Hsu R, Zhao G, et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med. 2006;203:2021-31. (Pubitemid 44188475)
8. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood. 2005;105:4191-9. (Pubitemid 40720762)
9. Bow EJ, Meddings JB. Intestinal mucosal dysfunction and infection during remission-induction therapy for acute mye-loid leukaemia. Leukemia. 2006;20:2087-92. (Pubitemid 44782833)
10. Straka C, Sandherr M, Salwender H, Wandt H, Metzner B, Hubel K, et al. Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy. Blood. 2011;117:2121-8.